Patents/Assignees

Modernatx, Inc.

95 patents in portfolio

US12233084utility2025
High Purity RNA Compositions and Methods for Preparation Thereof
0 cites
US12208288utility2025
Betacoronavirus RNA Vaccines
0 cites
US12195778utility2025
RNA Polymerase Variants
0 cites
US12180518utility2024
RNA Polymerase Variants for Co-transcriptional Capping
0 cites
US12150980utility2024
Concatemeric Peptide Epitope Rnas
0 cites
US12151029utility2024
PEG Lipids and Uses Thereof
0 cites
US12151995utility2024
Compounds and Compositions for Intracellular Delivery of Therapeutic Agents
0 cites
US12144895utility2024
Stabilized Formulations of Lipid Nanoparticles
0 cites
US12128113utility2024
Polynucleotides Encoding JAGGED1 for the Treatment of Alagille Syndrome
0 cites
US12123030utility2024
Polynucleotides Encoding Lipoprotein Lipase for the Treatment of Hyperlipidemia
0 cites
US12109274utility2024
Polynucleotides Containing a Stabilizing Tail Region
0 cites
US12103955utility2024
Polynucleotides Encoding Relaxin
0 cites
US12090235utility2024
Preparation of Lipid Nanoparticles and Methods of Administration Thereof
0 cites
US12077501utility2024
Compounds and Compositions for Intracellular Delivery of Agents
0 cites
US12071620utility2024
Polynucleotides Containing a Morpholino Linker
0 cites
US12042527utility2024
Use of Mrnas Encoding OX40L, IL-23 and Il-36gamma in Combination with Immune Checkpoint Blockade for Treating Particular Cancers
0 cites
US12023371utility2024
Terminally Modified RNA
0 cites
US11980672utility2024
Heterologous UTR Sequences for Enhanced Mrna Expression
0 cites
US11939601utility2024
Polynucleotides Encoding Phenylalanine Hydroxylase for the Treatment of Phenylketonuria
0 cites
US11918644utility2024
Varicella Zoster Virus (VZV) Vaccine
0 cites

← PreviousPage 3 of 5Next →